🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

FIVE at FIVE AU: Megaport and Altium fly high as Qantas faces class action over travel credits; Kinetiko shares soar

Published 22/08/2023, 04:00 pm
© Reuters FIVE at FIVE AU: Megaport and Altium fly high as Qantas faces class action over travel credits; Kinetiko shares soar
KOS
-
AIF
-
QAN
-
CLEGF
-
MP
-

The ASX is flat today, up just 3.40 points today to 7,118.90. The index has lost 2.55% for the last five days, but has gained 1.14% over the last year to date.

The top-performing stocks in this index are Altium Ltd and Megaport Ltd (ASX:MP1), up 25.60% and 16.94% respectively.

Altium will pay a higher final dividend following strong growth in the US and will ‘vigorously defend’ a multi-million-dollar legal dispute with the Australian Taxation Office.

The electronic design software company’s numbers were strong, with a drop in operating expenses lifting profit after tax to $US66.3 million up 19.6% from the previous year.

Altium grew its global subscriber base 7.5% to 61,159 up from 56,912 the previous year, which lifted revenue up by more than $US42 million compared to the past financial year, bringing in $US263.3 million.

Megaport expects earnings before interest, taxes, depreciation and amortisation in FY24 to be up to 182% higher at around $57 million. The company revised its April guidance and booked a $9.7 million loss for the full year ended June 30, down from the $48.5 million loss in FY22.

Guidance for FY24 EBITDA is to range between $51 million and $57 million, an increase of 152% to 182%, compared with its first-ever positive normalised EBITDA of $20.2 million for FY23. Revenue for the next financial year will likely range between $190 million and $195 million – higher than FY23’s $153.1 million.

On the downside, Coles Group Ltd was a drag on the local market suffering its worst day since 2020 after disappointing FY23 results.

The company lost 6.62% and finished at $16.09 –the biggest one-day fall since a 9.87% drop on March 31 2020 when COVID-19 lockdowns caused panic selling.

According to UBS, 2H23 Supermarkets EBIT was 9% below consensus.

Coles has been affected by lower gross general merchandise earnings due to theft, a rising cost of doing business due to labour costs, and Witron and Ocado (LON:OCDO) operating expenses.

Kogan was another whose shares fell sharply, down 11.91% today.

While its shares are up 50% over the last 12 months, Kogan has now reported its second consecutive loss – a full-year loss of $25.85 million for fiscal 2023.

Adjusted earnings are positive for the month of July.

Looking at the sectors, Information Technology had a great day jumping 5.06%, followed by Communication Services up 2.00%. Consumer Staples fell 2.54%.

Qantas class action

Surprisingly Qantas was higher, up 0.32% despite the threat of a class action over ‘hard to use’ travel credits.

Echo Law filed the action in the Federal Court, alleging Qantas acted in breach of the law by issuing travel credits with strict conditions in the place of refunds when flights were cancelled.

The firm alleges Qantas was “not entitled to hold onto its customers’ money and push out travel credits”.

“As customers sat at home and did it tough through the COVID pandemic, Qantas enjoyed significant financial benefits of holding on to billions of dollars in customer payments including interest and reduced borrowing costs,” solicitor Andrew Paull said.

“It is unfair and we allege unlawful, that Qantas profited from holding onto its customers money for flights that couldn’t proceed.”

It is also alleged that customers were “often required to pay the airline more than their original booking to use their credits on new fares”.

“(They) have been pressured by the airline to do that or lose the value of their flight credits,” Paull said.

The expiration of flight credits is also an issue.

“That money ought to have been automatically returned to customers, in most cases more than three years ago, and we are seeking both refunds of all remaining credits as well as compensation for the time customers have been out of pocket,” he said.

Qantas refuted the claims saying it processed more than $1 billion in refunds from COVID credits.

“The majority of customers with COVID credits can get a refund and we’ve been running full-page ads and sending emails to encourage customers who want a refund to contact us directly,” a Qantas spokesperson said.

“Qantas has one of the most flexible COVID credit policies of any airline, including among our global peers, and we’ve extended the expiry dates three times.”

Five at five

The S&P/ASX Small Ordinaries finished 0.61% higher, with several companies putting out positive news.

Kinetiko Energy and IDC to jointly develop South Africa’s largest onshore LNG project; shares soar

Kinetiko Energy Ltd (ASX:KKO, OTC:KKOEF) has soared after taking a massive step in its objective to provide a sustainable cleaner energy solution for South Africa by executing an agreement with the Industrial Development Corporation of South Africa (IDC) to co-develop a new joint venture for the appraisal and production of LNG to deliver 50MW growing to 500MW gas equivalent energy.

Read more

International Graphite caps 2022-23 drilling campaign with strong graphite intersections paving way for new resource estimate

International Graphite Ltd (ASX:IG6) has capped off a highly successful 2022-23 drilling campaign at the flagship Springdale Graphite Project in Western Australia with yet more high-grade graphite.

Read more

Recce Pharmaceuticals has patients dosed in Phase I/II diabetic foot infection clinical trial

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has dosed patients in a Phase I/II diabetic foot infection (DFI) clinical trial, testing the safety and efficacy of RECCE® 327 (R327).

Read more

CuFu delivers significant rare earth elements, 43.93% niobium, 15% tantalum and lithium results

CuFe Ltd (ASX:CUF) has delivered significant initial rare earth elements, niobium and lithium rock chip samples during early-stage exploration at its North Dam Project in Western Australia.

Read more

Incannex Healthcare receives US FDA approval for sleep apnoea clinical trial

Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has received clearance from the US Food and Drug Administration (FDA) to begin the Phase 2/3 clinical trial for its IHL-42X asset, designed to address obstructive sleep apnoea (OSA).

Read more

On your six

China bolsters domestic lithium mining amid geopolitical concerns and surging global demand

Chinese enterprises are amplifying their efforts to tap into domestic lithium resources to reduce their dependence on foreign sources given current geopolitical tensions and rising global demand, according to a report in the Wall Street Journal.

Read more

The one to watch

Azure Minerals says Andover one of best lithium exploration plays globally

Azure Minerals Ltd (ASX:AZS, OTC:AZRMF) MD Tony Rovira speaks with Proactive after announcing the company has received firm commitments to raise $120 million as it looks to accelerate exploration and resource drilling at the high-grade Andover Lithium Project in Western Australia’s West Pilbara region.

Watch

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.